Ergebnis ihrer Suche nach Mitteilungen

DGAP-News 22.05.13 22:01 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Announces Proposed Public Offering of Comm[...]
NASDAQ OMX-News 22.05.13 22:01 NASDAQ OMX-News: Apricus Biosciences, Inc.
Apricus Biosciences Announces Proposed Public Offering of Comm[...]
DGAP-News 10.05.13 14:30 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Provides First Quarter 2013 Corporate Update
DGAP-News 07.05.13 20:39 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Announces First Quarter 2013 Financial Res[...]
DGAP-News 01.04.13 22:00 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Announces Sale of Non-Core Assets
DGAP-News 18.03.13 16:15 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Provides Corporate Update; Files Annual Re[...]
DGAP-News 18.03.13 16:00 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Appoints Richard W. Pascoe as Chief Execut[...]
DGAP-News 14.03.13 14:00 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Announces 2012 Year End Financial Results [...]
DGAP-News 14.03.13 13:54 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Announces Ceasing of Financing of French S[...]
DGAP-News 07.03.13 14:00 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences to Present at BIO-Europe Spring 2013
DGAP-News 21.11.12 12:30 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences to Present at the 24th Annual Piper Jaffra[...]
NASDAQ OMX-News 21.11.12 12:30 NASDAQ OMX-News: Apricus Biosciences, Inc.
Apricus Biosciences to Present at the 24th Annual Piper Jaffra[...]
DGAP-News 08.11.12 15:00 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences' Executives to Present at Two Upcoming Con[...]
NASDAQ OMX-News 08.11.12 15:00 NASDAQ OMX-News: Apricus Biosciences, Inc.
Apricus Biosciences' Executives to Present at Two Upcoming Con[...]
DGAP-News 07.11.12 13:30 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Announces Third Quarter 2012 Financial Res[...]
NASDAQ OMX-News 07.11.12 13:30 NASDAQ OMX-News: Apricus Biosciences, Inc.
Apricus Biosciences Announces Third Quarter 2012 Financial Res[...]
DGAP-News 06.11.12 23:46 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Announces Management Changes
NASDAQ OMX-News 06.11.12 23:46 NASDAQ OMX-News: Apricus Biosciences, Inc.
Apricus Biosciences Announces Management Changes
DGAP-News 18.10.12 12:00 DGAP-News: Apricus Biosciences, Inc.
Apricus Biosciences Receives $2.5 Million Payment From Abbott [...]
NASDAQ OMX-News 18.10.12 12:00 NASDAQ OMX-News: Apricus Biosciences, Inc.
Apricus Biosciences Receives $2.5 Million Payment From Abbott [...]

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Event im Fokus

38. m:access Analystenkonferenz München

Datum: 06.06.2013
Zeit: 9:30 Uhr - 17.00 Uhr
Ort: Börse München



Aktuelle Research-Studie

Viscom AG

Original-Research: Viscom AG (von Vara Research GmbH): Halten

22. Mai 2013